Where it is registered
Each register with its number of medicines and a few of them.
Taiwan
TFDA · 3 medicines · Historical list
United States
FDA · 3 medicines
All medicines with Tromethamine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
27 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Tromethamine | United States | 18GM/500ML | solution | Marketed | B Braun Medical |
| Tham | United States | 18GM/500ML | solution | Marketed | Hospira |
| Ketorolac Tromethamine | United States | 10MG | tablet | Marketed | Zydus Lifesciences |
| Ketorolac Tromethamine | United States | 15MG/ML, 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG/ML … | injectable | Marketed | Onesource Specialty |
| Ketorolac Tromethamine | United States | 0.4%, 0.45%, 0.5% | solution/drops | Marketed | Apotex |
| Carboprost Tromethamine | United States | 0.25MG BASE/ML | injectable | Marketed | Ani Pharms |
| Fosfomycin Tromethamine | United States | 3GM BASE/PACKET | for solution | Marketed | Xiromed |
| Tham-ECombination | United States | 370MG/VIAL; 1.75GM/VIAL; 36GM/VIAL | injectable | Not marketed | Hospira |
| Ketorolac Tromethamine and Phenylephrine HydrochlorideCombination | United States | 0.3% BASE; 1% BASE | solution | Marketed | Lupin |
| Acular LS | United States | 0.4% | solution/drops | Marketed | Abbvie |
| Acuvail | United States | 0.45% | solution/drops | Marketed | Abbvie |
| Hemabate | United States | 0.25MG BASE/ML | injectable | Marketed | Pfizer |
| OmidriaCombination | United States | 0.3% BASE; 1% BASE | solution | Marketed | Rayner Surgical |
| Trophamine | United States | 6% | injectable | Marketed | B Braun |
| Acular | United States | 0.5% | solution/drops | Marketed | Abbvie |
| Rukobia | United States | 600MG BASE | tablet, extended release | Marketed | Viiv Hlthcare |
| Sprix | United States | 15.75MG/SPRAY | spray, metered | Marketed | Zyla |
| Toradol | United States | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet | Not marketed | Roche Palo |
| Toradol | United States | 15MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 30MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable | Not marketed | Roche Palo |
| Ketorocaine L KitCombination | United States | Status unknown | |||
| Ketorocaine LM KitCombination | United States | Status unknown | |||
| Acular Preservative Free | United States | 0.5% | solution/drops | Not marketed | Allergan |
| Alomide | United States | 0.1% BASE | solution/drops | Not marketed | Novartis |
| Monurol | United States | 3GM BASE/PACKET **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | for solution | Not marketed | Zambon SPA |
| Prostin F2 Alpha | United States | 5MG BASE/ML | injectable | Not marketed | Pharmacia and Upjohn |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Often combined with
Substances it shares a medicine with.
Sources
Compiled by Prognia from the public medicine registers of FDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 2
- Medicines
- 6
- Companies
- 4